Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Nov 2024 for Protagonist Therapeutics, Inc, €317k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Suneel Gupta: trading record in brief
All filings by Suneel Gupta on record concern Protagonist Therapeutics, Inc, in the capacity of senior executive. We count 10 filings; the first trade dates from 15 February 2022 and the latest from 25 November 2024.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 27 November 2024 with an option exercise (€317k) in Protagonist Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Suneel Gupta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
45,000 shares@ US$7.3835.3% of flowCommon StockSEC:0001104659-24-123807:0
4,282 shares@ US$29.5313.0% of flowCommon StockSEC:0001104659-24-028886:0
5,000 shares@ US$7.383.8% of flowCommon StockSEC:0001104659-24-003435:0
19,250 shares0Common StockSEC:0001104659-24-001495:0
20,000 shares@ US$7.3815.5% of flowCommon StockSEC:0001104659-23-110803:0
12,000 shares0Common StockSEC:0001104659-23-067691:0
20,625 shares0Common StockSEC:0001104659-23-004730:0
40,000 shares@ US$7.3830.9% of flowCommon StockSEC:0001104659-22-050560:0
649 shares@ US$24.281.6% of flowCommon StockSEC:0001104659-22-029522:0
12,500 shares0Common StockSEC:0001104659-22-024838:0
10 of 10 declarations
